Prevalence of HPV high and low risk types in cervical samples from the Italian general population: A population based study

BMC Infectious Diseases

Volumn 10, Issue , 2010, Pages

  Giorgi Rossi, Paolo ^a   Bisanzi, Simonetta ^b   Paganini, Irene ^b   Di Iasi, Angela ^c   Angeloni, Claudio ^d   Scalisi, Aurora ^e   Macis, Rosalba ^f   Pini, Maria T ^g   Chini, Francesco ^a   Carozzi, Francesca M ^b  

^a Agency for Public Health   (Italy)

^b ISPO   (Italy)

^c Ospedale SC Moscati   (Italy)

^d ASL Teramo   (Italy)

^e ASL Catania   (Italy)

^f Territorial Department of Nephrology and Dialysis   (Italy)

^g Dipartimento Materno Infantile ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SCREENING; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN TISSUE; INFECTION RISK; ITALY; MIXED INFECTION; POLYMERASE CHAIN REACTION; RISK ASSESSMENT; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; CLASSIFICATION; CLINICAL TRIAL; GENETICS; ISOLATION AND PURIFICATION; MIDDLE AGED; MULTICENTER STUDY; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTION; PREVALENCE; UTERINE CERVIX; VAGINA SMEAR; VIROLOGY;

VIRUS DNA;

ADULT; AGED; CERVIX UTERI; DNA, VIRAL; FEMALE; HUMANS; ITALY; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PREVALENCE; VAGINAL SMEARS;

EID: 77954679515     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-10-214     Document Type: Article

References (37)

1. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999, 189:12-9. 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F, 10451482.
2. Intesa del 20 dicembre 2007 tra il Ministero della Salute le Regioni e le Province Autonome di Trento e Bolzano. "Strategia per l'offerta attiva del vaccino contro l'infezione da HPV in Italia"
3. Ronco G, Segnan N, Giorgi-Rossi P, Zappa M, Casadei GP, Carozzi F, Dalla Palma P, Del Mistro A, Folicaldi S, Gillio-Tos A, Nardo G, Naldoni C, Schincaglia P, Zorzi M, Confortini M, Cuzick J. New Technologies for Cervical Cancer Working Group. Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial. J Natl Cancer Inst 2006, 98:765-74. 10.1093/jnci/djj209, 16757701.
4. Ronco G, Giorgi-Rossi P, Carozzi F, Dalla Palma P, Del Mistro A, De Marco L, De Lillo M, Naldoni C, Pierotti P, Rizzolo R, Segnan N, Schincaglia P, Zorzi M, Confortini M, Cuzick J. New Technologies for Cervical Cancer screening Working Group. Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial. Lancet Oncol 2006, 7:547-55. 10.1016/S1470-2045(06)70731-8, 16814206.
5. Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla Palma P, Del Mistro A, Gillio-Tos A, Minucci D, Naldoni C, Rizzolo R, Schincaglia P, Volante R, Zappa M, Zorzi M, Cuzick J, Segnan N. New Technologies for Cervical Cancer Screening Working Group. Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test. J Natl Cancer Inst 2008, 100:492-501. Epub 2008 Mar 25, 10.1093/jnci/djn065, 18364502.
6. Centurioni MG, Puppo A, Merlo DF, Pasciucco G, Cusimano ER, Sirito R, Gustavino CA. Prevalence of human papillomavirus cervical infection in an Italian asymptomatic population. BMC Infect Dis 2005, 5:77. 10.1186/1471-2334-5-77, 1249574, 16188026.
7. Tornesello ML, Duraturo ML, Giorgi-Rossi P, Sansone M, Piccoli R, Buonaguro L, Buonaguro FM. Human papillomavirus (HPV) genotypes and HPV16 variants in human immunodeficiency virus-positive Italian women. J Gen Virol 2008, 89:1380-9. 10.1099/vir.0.83553-0, 18474553.
8. Ronco G, Ghisetti V, Segnan N, Snijders PJ, Gillio-Tos A, Meijer CJ, Merletti F, Franceschi S. Prevalence of human papillomavirus infection in women in Turin, Italy. Eur J Cancer 2005, 41:297-305. 10.1016/j.ejca.2004.07.005, 15661556.
9. Ammatuna P, Giovannelli L, Matranga D, Ciriminna S, Perino A. Prevalence of genital human papilloma virus infection and genotypes among young women in Sicily, South Italy. Cancer Epidemiol Biomarkers Prev 2008, 17:2002-6. 10.1158/1055-9965.EPI-08-0180, 18708390.
10. AIRTum Banca dati AIRTum (last access 1/2/2010), AIRTum Banca dati AIRTum., http://www.registri-tumori.it/cms/?q=node/17
11. ISTAT - Unit Struttura e dinamica sociale. Health interview survey Health status and use of health services - Years 2004-2005. 2006, ISTAT Roma, ISTAT - Unit Struttura e dinamica sociale. Health interview survey.
12. Ronco G, Giubilato P, Naldoni C, Zorzi M, Anghinoni E, Scalisi A, Dalla Palma P, Zanier L, Barca A, Gaimo MD, Maglietta R, Mancini E, Pizzuti R, Iossa A, Segnan N, Zappa M. Extension of organised cervical cancer screening programmes in Italy and their process indicators: 2007 activity. Epidemiol Prev 2009, 33(3 Suppl 2):41-56.
13. von Karsa L, Anttila A, Ronco G, Ponti A, Malila N, Arbyn M, Segnan N, Castillo-Beltran M, Boniol M, Ferlay J, Hery C, Sauvaget C, Voti L, Autier P. Cancer Screening in the European Union. Report on the Implementation of the Council Recommendation on Cancer Screening. First Report 2008, City of Luxembourg, Grand Duchy of Luxembourg: Services of the European Commission.
14. European Commission Report from the Commission to the Council, the European Parliament, the European Economic and Social Committee and the Committee of the Regions. Implementation of the Council Recommendation of 2 December 2003 on Cancer Screening (2003/878/EC) 2008, Brussels, Belgium: Commission of the European Communities, 22.12.2008. COM 2008; 882 final, European Commission.
15. Cogliano V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F. WHO International Agency for Research on Cancer. Carcinogenicity of human papillomaviruses. Lancet Oncol 2005, 6:204. 10.1016/S1470-2045(05)70086-3, 15830458.
16. Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, Snijders PJ, Meijer CJ. International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003, 348:518-27. 10.1056/NEJMoa021641, 12571259.
17. Arbyn M, Dillner J. Review of current knowledge on HPV vaccination: an appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening. J Clin Virol 2007, 38:189-97. 10.1016/j.jcv.2006.12.009, 17258503.
18. Carozzi FM, Del Mistro A, Confortini M, Sani C, Puliti D, Trevisan R, De Marco L, Tos AG, Girlando S, Palma PD, Pellegrini A, Schiboni ML, Crucitti P, Pierotti P, Vignato A, Ronco G. Reproducibility of HPV DNA Testing by Hybrid Capture 2 in a Screening Setting. Am J Clin Pathol 2005, 124:716-21. 10.1309/84E5WHJQHK83BGQD, 16203283.
19. Van den Brule AJ, Pol R, Fransen-Daalmeijer N, Schouls LM, Meijer CJ, Snijders PJ. GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol 2002, 40:779-87. 10.1128/JCM.40.3.779-787.2002, 120256, 11880393.
20. Bauer HM, Greer CE, Manos MM. Determination of genital human papillomavirus infection using consensus PCR. Diagnostic molecular pathology: a practical approach 1992, 132-152. Oxford University Press, Oxford, United Kingdom, Herrington CS, McGee JOD.
21. Walboomers JMM, Melkert PWJ, Van Den Brule AJC, Snijders PJF, Meijer CJLM. The polymerase chain reaction for human papillomavirus screening in diagnostic cytopathology of the cervix. A practical approach 1992, Oxford University Press, Oxford, United Kingdom, Herrington CS, McGee JOD.
22. Stata Statistical Software Release 8.0 College Station. TX: Stata Corporation, Stata Statistical Software.
23. Castle PE, Schiffman M, Burk RD, Wacholder S, Hildesheim A, Herrero R, Bratti MC, Sherman ME, Lorincz A. Restricted Cross-Reactivity of Hybrid Capture 2 with Nononcogenic Human Papillomavirus Types. Cancer Epidemiol Biomark Prev 2002, 11:1394-9.
24. Astori G, Arzese A, Pipan C, de Villiers EM, Botta GA. Characterization of a putative new HPV genomic sequence from a cervical lesion using L1 consensus primers and restriction fragment length polymorphism. Virus Res 1997, 50:57-63. 10.1016/S0168-1702(97)00054-3, 9255935.
25. Tornesello ML, Duraturo ML, Botti G, Greggi S, Piccoli R, De Palo G, Montella M, Buonaguro L, Buonaguro FM, . Italian HPV Working Group Prevalence of alpha-papillomavirus genotypes in cervical squamous intraepithelial lesions and invasive cervical carcinoma in the Italian population. J Med Virol 2006, 78:1663-72. 10.1002/jmv.20752, 17063505, Italian HPV Working Group.
26. Tornesello ML, Duraturo ML, Buonaguro L, Vallefuoco G, Piccoli R, Palmieri S, Buonaguro FM. Prevalence of human papillomavirus genotypes and their variants in high risk West Africa women immigrants in South Italy. Infect Agent Cancer 2007, 2:1. 10.1186/1750-9378-2-1, 1779264, 17201927.
27. Del Prete R, Di Taranto AM, Lipsi MR, Nirchio V, Antonetti R, Miragliotta G. Prevalence and genotypes identification of human papillomavirus infection in a population of South Italy. J Clin Virol 2008, 42:211-4. Epub 2008 Mar 14, 10.1016/j.jcv.2008.01.011, 18339580.
28. Agarossi A, Ferrazzi E, Parazzini F, Perno CF, Ghisoni L. Prevalence and type distribution of high-risk human papillomavirus infection in women undergoing voluntary cervical cancer screening in Italy. J Med Virol 2009, 81:529-35. 10.1002/jmv.21347, 19152401.
29. Giovannelli L, Vassallo R, Matranga D, Affronti M, Caleca MP, Bellavia C, Perino A, Ammatuna P. Prevalence of cervical human papillomavirus infection and types among women immigrated to Sicily, Italy. Acta Obstet Gynecol Scand 2009, 88:737-42. 10.1080/00016340902952318, 19412805.
30. Masia G, Mazzoleni AP, Contu G, Laconi S, Minerba L, Montixi S, Montis F, Onano A, Porcedda E, Coppola RC. Epidemiology and genotype distribution of human papillomavirus (HPV) in women of Sardinia (Italy). Vaccine 2009, 27(Suppl 1):A11-6. 10.1016/j.vaccine.2008.10.095, 19480954.
31. Verteramo R, Pierangeli A, Mancini E, Calzolari E, Bucci M, Osborn J, Nicosia R, Chiarini F, Antonelli G, Degener AM. Human Papillomaviruses and genital co-infections in gynaecological outpatients. BMC Infect Dis 2009, 9:16. 10.1186/1471-2334-9-16, 2656516, 19216747.
32. De Angelis R, Rossi S, Martina L. Gruppo di lavoro AIRTUM and Capocaccia R. Stima di incidenza e mortalità per cervico-carcinoma (CC) in Italia. Rapporto Istisan, ISS, Roma, .
33. Progressi delle Aziende Sanitarie per la Salute in Italia (last access 26/03/2010), Progressi delle Aziende Sanitarie per la Salute in Italia., http://www.epicentro.iss.it/passi/report_2008.asp
34. Franceschi S, Herrero R, Clifford GM, Snijders PJ, Arslan A, Anh PT, Bosch FX, Ferreccio C, Hieu NT, Lazcano-Ponce E, Matos E, Molano M, Qiao YL, Rajkumar R, Ronco G, de Sanjosé S, Shin HR, Sukvirach S, Thomas JO, Meijer CJ, Muñoz N. Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int J Cancer 2006, 119:2677-84. 10.1002/ijc.22241, 16991121.
35. Deiana L, Ferrucci L, Pes GM, Carru C, Delitala G, Ganau A, Mariotti S, Nieddu A, Pettinato S, Putzu P, Franceschi C, Baggio G. AKEntAnnos. The Sardinia Study of Extreme Longevity. Aging (Milano) 1999, 11(3):142-9.
36. Ronco G, Segnan N, Giordano L, Pilutti S, Senore C, Ponti A, Volante R. Interaction of spontaneous and organised screening for cervical cancer in Turin, Italy. Eur J Cancer 1997, 33:1262-7. 10.1016/S0959-8049(97)00076-2, 9301453.
37. Giorgi Rossi P, Esposito G, Brezzi S, Brachini A, Raggi P, Federici A. Estimation of Pap-test coverage in an area with an organised screening program: challenges for survey methods. BMC Health Serv Res 2006, 6:36. 10.1186/1472-6963-6-36, 1435881, 16545125.